I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Arnason, Jon
134
results:
english X
Search for persons
X
Format
Online (133)
Print (1)
Mediatypes
Articles (Online) (77)
Articles (Print) (1)
Bookchapter (Online) (1)
OpenAccess-fulltext (55)
Sorted by: Relevance
Sorted by: Year
?
1
Plain language summary of the TRANSFORM study primary analy..:
Abramson, Jeremy S
;
Solomon, Scott R
;
Arnason, Jon
...
Future Oncology. , 2024
Link:
https://doi.org/10.2217/..
?
2
Five-year follow-up of a phase 2 study of ibrutinib plus fl..:
Ahn, Inhye E.
;
Brander, Danielle M.
;
Ren, Yue
...
Blood Advances. 8 (2024) 4 - p. 832-841 , 2024
Link:
https://doi.org/10.1182/..
?
3
Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) with R..:
Palomba, M. Lia
;
Siddiqi, Tanya
;
Gordon, Leo I.
...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S14 , 2024
Link:
https://doi.org/10.1016/..
?
4
Lisocabtagene maraleucel as second-line therapy for large B..:
Abramson, Jeremy S.
;
Solomon, Scott R.
;
Arnason, Jon
...
Blood. 141 (2023) 14 - p. 1675-1684 , 2023
Link:
https://doi.org/10.1182/..
?
5
Targeting CD19 for diffuse large B cell lymphoma in the era..:
Sermer, David
;
Elavalakanar, Pavania
;
Abramson, Jeremy S.
...
Blood Reviews. 57 (2023) - p. 101002 , 2023
Link:
https://doi.org/10.1016/..
?
6
Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and..:
Hasan, Haytham
;
Surjancev, Ivana
;
Arnason, Jon A.
...
Case Reports in Rheumatology. 2023 (2023) - p. 1-5 , 2023
Link:
https://doi.org/10.1155/..
?
7
MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R MCL: Pri..:
Palomba, M. Lia
;
Siddiqi, Tanya
;
Gordon, Leo I.
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S458 , 2023
Link:
https://doi.org/10.1016/..
?
8
Primary Analysis (PA) Results from the Randomized, Phase 3 ..:
Abramson, Jeremy S.
;
Solomon, Scott R.
;
Arnason, Jon
...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S36-S37 , 2023
Link:
https://doi.org/10.1016/..
?
9
POSTER: MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R ..:
Palomba, M. Lia
;
Siddiqi, Tanya
;
Gordon, Leo I.
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S213 , 2023
Link:
https://doi.org/10.1016/..
?
10
2694. Infectious Complications in CAR-T Cell Therapy Recipi..:
Banegas, Marcela
;
Bindal, Poorva
;
Woodbine, Maria Jose Hernandez
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
11
Clonal myeloid disorders following CAR T-cell therapy:
Andersen Jr, Michael
;
Bindal, Poorva
;
Michaels, Phillip
...
Annals of Hematology. 102 (2023) 12 - p. 3643-3645 , 2023
Link:
https://doi.org/10.1007/..
?
12
Lisocabtagene maraleucel versus standard of care with salva..:
Kamdar, Manali
;
Solomon, Scott R
;
Arnason, Jon
...
The Lancet. 399 (2022) 10343 - p. 2294-2308 , 2022
Link:
https://doi.org/10.1016/..
?
13
Health-related quality of life with lisocabtagene maraleuce..:
Abramson, Jeremy S.
;
Johnston, Patrick B.
;
Kamdar, Manali
...
Blood Advances. 6 (2022) 23 - p. 5969-5979 , 2022
Link:
https://doi.org/10.1182/..
?
14
Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel..:
Siddiqi, Tanya
;
Soumerai, Jacob D.
;
Dorritie, Kathleen A.
...
Blood. 139 (2022) 12 - p. 1794-1806 , 2022
Link:
https://doi.org/10.1182/..
?
15
Complete responses to odronextamab in two patients with dif..:
Weinstock, Matt
;
Elavalakanar, Pavania
;
Bright, Susan
...
British Journal of Haematology. 199 (2022) 3 - p. 366-370 , 2022
Link:
https://doi.org/10.1111/..
1-15